全文获取类型
收费全文 | 127916篇 |
免费 | 12973篇 |
国内免费 | 8785篇 |
专业分类
耳鼻咽喉 | 1038篇 |
儿科学 | 1693篇 |
妇产科学 | 979篇 |
基础医学 | 10773篇 |
口腔科学 | 2382篇 |
临床医学 | 15353篇 |
内科学 | 14023篇 |
皮肤病学 | 1193篇 |
神经病学 | 4770篇 |
特种医学 | 5265篇 |
外国民族医学 | 39篇 |
外科学 | 13087篇 |
综合类 | 30822篇 |
现状与发展 | 28篇 |
一般理论 | 16篇 |
预防医学 | 11953篇 |
眼科学 | 2217篇 |
药学 | 14784篇 |
165篇 | |
中国医学 | 10904篇 |
肿瘤学 | 8190篇 |
出版年
2024年 | 375篇 |
2023年 | 1679篇 |
2022年 | 3644篇 |
2021年 | 5568篇 |
2020年 | 4716篇 |
2019年 | 3210篇 |
2018年 | 3486篇 |
2017年 | 3882篇 |
2016年 | 3223篇 |
2015年 | 5517篇 |
2014年 | 7052篇 |
2013年 | 7853篇 |
2012年 | 11482篇 |
2011年 | 12409篇 |
2010年 | 9924篇 |
2009年 | 8351篇 |
2008年 | 9095篇 |
2007年 | 8843篇 |
2006年 | 8086篇 |
2005年 | 6910篇 |
2004年 | 4860篇 |
2003年 | 4122篇 |
2002年 | 3428篇 |
2001年 | 2916篇 |
2000年 | 2428篇 |
1999年 | 1479篇 |
1998年 | 828篇 |
1997年 | 791篇 |
1996年 | 634篇 |
1995年 | 571篇 |
1994年 | 431篇 |
1993年 | 304篇 |
1992年 | 262篇 |
1991年 | 208篇 |
1990年 | 201篇 |
1989年 | 195篇 |
1988年 | 148篇 |
1987年 | 133篇 |
1986年 | 103篇 |
1985年 | 100篇 |
1984年 | 54篇 |
1983年 | 33篇 |
1982年 | 33篇 |
1981年 | 25篇 |
1980年 | 15篇 |
1979年 | 17篇 |
1978年 | 7篇 |
1973年 | 5篇 |
1972年 | 6篇 |
1971年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
51.
52.
目的 对促甲状腺素(TSH) 抑制治疗期间的分化型甲状腺癌(DTC)患者进行膳食调查,为对患者进行个性化膳食指导及营养干预研究提供参考依据。方法 从湖南省肿瘤医院甲状腺内科的门诊患者中收集行TSH抑制治疗的DTC患者,根据抑制治疗副作用危险分层标准,收集低、中、高危患者各200例,共600例患者作为研究对象。对所有入选病例进行膳食调查:一年食物摄入频率和3天24小时回顾法膳食调查。结果 TSH抑制治疗的DTC患者整体人群膳食摄入不足且膳食结构不合理;整体人群畜肉类摄入过多,鱼类及水产品、蛋、奶、豆、蔬菜、水果则摄入过少;整体人群脂类、碳水化合物、维生素E摄入量基本达到要求;蛋白质、膳食纤维、钙、铁、锌、硒、维生素A、维生素B1、维生素B2、维生素C、烟酸摄入明显不足;碘摄入基本符合要求;低、中、高危组膳食摄入不足率分别是21.0%、8.0%、11.5%;中危组畜肉类摄入最多,碘摄入有0.5%的患者超标;高危组牛奶摄入最少。结论 TSH抑制治疗的DTC患者膳食结构不合理及多种营养素摄入不足,在临床工作中应加强对整体人群的营养教育及针对性的干预,以降低TSH抑制治疗对心血管系统及影响骨代谢的风险。 相似文献
53.
青光眼是致盲的主要原因之一,构成视神经的神经节细胞轴突受到多种因素的损伤,其机制尚未完全明了。青光眼最重要的危险因素是眼压升高。由于青光眼的视神经损伤尚不能直接治疗,根据目前提供的唯一已知可治疗的危险因素,可以降低升高的眼压,而眼压与房水流出通道的功能息息相关。这些方面的药物均可以影响青光眼的进展。随着医疗技术的发展以及对青光眼发病机制认识的加深,新型抗青光眼药物也应运而生,为眼科医师提供新的选择。本文将对国内外新型抗青光眼药物从机制、药理特点及临床疗效等方面进行综述。 相似文献
54.
目的观察关节镜下采用自体腘绳肌腱经胫骨隧道前交叉韧带(anterior cruciate ligament, ACL)双束八股解剖重建的临床效果。方法随访上海交通大学附属第六人民医院运动医学科2018年12月—2020年1月收治的103例ACL断裂患者资料,其中男78例,女25例,年龄18~45岁,平均(26.8±5.86)岁;左侧47例,右侧56例,均采用关节镜下自体腘绳肌腱经胫骨隧道打股骨骨隧道,ACL双束八股解剖重建。按照Lysholm评分、国际膝关节评分委员会(IKDC)膝关节评分、Tegner膝关节评分标准和膝关节自我效能量表K-SES评价疗效。结果所有患者术后获随访12~42个月,平均(24±8.18)个月;手术前、末次随访评分比较,Lysholm评分分别为(48.41±4.44)分和(95.34±1.91)分,2组比较差异有统计学意义(P<0.001);IKDC评分分别为(44.05±4.36)分和(95.66±1.89)分,2组比较差异有统计学意义(P<0.001);Tegner评分分别为(2.84±0.95)分和(6.15±0.89)分,2组比较差异有统计学意义(P<0.001);膝关节自我效能量表K-SES量表(3.10±0.83)分和(7.12±1.10)分,2组比较差异有统计学意义(P<0.001)。末次随访103例患者前抽屉试验阴性,轴移试验阴性。98例(95.1%)Lachman试验阴性,5例(4.9%)Lachman试验1°阳性。结论关节镜下采用自体腘绳肌腱经胫骨隧道双束八股解剖重建前交叉韧带是一种恢复膝关节稳定性,恢复伤前活动水平的有效方法。 相似文献
55.
56.
Discoid lupus erythematosus (DLE) is the most common skin manifestation of lupus; however, the molecular mechanisms underlying DLE remain unknown. Therefore, we aimed to identify key differentially expressed genes (DEGs) in discoid lupus skin and investigate their potential pathways.To identify candidate genes involved in the occurrence and development of the disease, we downloaded the microarray datasets and GSE52471 from the Gene Expression Database (GEO). DEGs between discoid lupus skin and normal controls were selected using the GEO2R tool and Venn diagram software ( GSE72535http://bioinformatics.psb.ugent.be/webtools/Venn/). The Database for Annotation, Visualization, and Integrated Discovery (DAVID), Enrichr, and Cytoscape ClueGo were used to analyze the Kyoto Encyclopedia of Gene and Genome pathways and gene ontology. Protein-protein interactions (PPIs) of these DEGs were further assessed using the Search Tool for the Retrieval Interacting Genes version 10.0.Seventy three DEGs were co-expressed in both datasets. DEGs were predominantly upregulated in receptor signaling pathways of the immune response. In the PPI network, 69 upregulated genes were selected. Furthermore, 4 genes (CXCL10, ISG15, IFIH1, and IRF7) were found to be significantly upregulated in the RIG-I-like receptor signaling pathway, from analysis of Enrichr and Cytoscape ClueGo.The results of this study may provide new insights into the potential molecular mechanisms of DLE. However, further experimentation is required to confirm these findings. 相似文献
57.
Xiaojie Wu Leyan Zhang Jiadi Zhou Luying Liu Qiang Fu Aili Fu Xiaoying Feng Rui Xin Hongrui Liu Yong Gao Jiangnan Xue 《Current problems in cancer》2019,43(1):18-26
Aim
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an immune inhibitory receptor which is expressed within most types of hematopoietic cells and negatively regulates immune responses. Recently, we found LAIR-1 expression to be present within tumors of nonhematopoietic lineages. However, the roles of LAIR-1 in hepatocellular carcinoma (HCC) have yet to be examined. The purpose of this study was to investigate the expression of LAIR-1 in HCC tissue and assess its clinical significance at this site.Materials and methods
Expression levels of LAIR-1 within HCC samples collected from 90 patients and compared with that of slides of normal liver tissue collected from 9 non-HCC patients were measured by immunohistochemistry using tissue microarrays. A semiquantitative score was assigned, as was based on staining intensity and percent of positive cells and a Spearman Rank correlation test was used to assess any potential significant correlations between LAIR-1 expression and clinicopathological factors. Overall survival analysis was performed using the Kaplan-Meier and Log Rank statistical test.Results
LAIR-1 expression was detected in cancer tissue and adjacent tumor tissue, but not in normal liver tissue. The percent of LAIR-1-positive expression in cancer tissue of HCC samples was 97.78% (88/90) while that in adjacent tumor tissue was 96.67% (87/90). Significantly greater expression levels of LAIR-1 were obtained from cancer tissue (Mean?±?SD?=?5.722?±?2.145) than that in adjacent tumor tissue (4.141?±?1.486). In addition, LAIR-1 expression was found to be significantly correlated with pathological grade of HCC, T stage, and age. Expression levels of LAIR-1 were related with worse overall survival rates of HCC patients, especially in HCC patients with hepatic cirrhosis.Conclusion
Results of this study show that LAIR-1 is expressed in HCC tissues and that high levels of LAIR-1 expression are associated with the poor cancer differentiation. In addition, overexpression of LAIR-1 was significantly associated with worse overall survival in the patients with HCC. These data suggest that LAIR-1 may be an independent predictor for clinical outcomes in patients with HCC. 相似文献58.
59.
60.